Edgestream Partners, L.P. Vertex Pharmaceuticals Inc Transaction History

Edgestream Partners, L.P.

$3.48 Billion
Q2 2025

A detailed history of Edgestream Partners, L.P. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Edgestream Partners, L.P. holds 6,415 shares of VRTX stock, worth $2.59 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

6,415

Previous 738 769.24%

Holding current value

$2.59 Million

Previous $357,000 699.72%

% of portfolio

0.08%

Previous 0.01%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	BUY	$421.16 - $509.5 $2.39 Million - $2.89 Million	5,677 Added 769.24%	6,415 $2.86 Million
Q1 2025 May 01, 2025	SELL	$402.49 - $513.76 $2.05 Million - $2.62 Million	-5,104 Reduced 87.37%	738 $357,000
Q4 2024 Feb 06, 2025	BUY	$396.64 - $516.74 $1.44 Million - $1.88 Million	3,640 Added 165.3%	5,842 $2.35 Million
Q3 2024 Nov 14, 2024	SELL	$460.0 - $505.78 $213,440 - $234,681	-464 Reduced 17.4%	2,202 $1.02 Million
Q2 2024 Aug 09, 2024	SELL	$392.81 - $485.53 $3.92 Million - $4.85 Million	-9,988 Reduced 78.93%	2,666 $1.25 Million
Q1 2024 May 10, 2024	BUY	$407.69 - $446.08 $4.85 Million - $5.31 Million	11,908 Added 1596.25%	12,654 $5.29 Million
Q4 2023 Feb 14, 2024	SELL	$343.0 - $410.68 $911,008 - $1.09 Million	-2,656 Reduced 78.07%	746 $303,000
Q3 2023 Nov 14, 2023	BUY	$338.18 - $362.46 $332,092 - $355,935	982 Added 40.58%	3,402 $1.18 Million
Q2 2023 Aug 10, 2023	BUY	$314.42 - $351.91 $760,896 - $851,622	2,420 New	2,420 $851,000
Q3 2022 Nov 14, 2022	BUY	$273.83 - $305.53 $630,630 - $703,635	2,303 Added 83.29%	5,068 $1.47 Million
Q2 2022 Aug 12, 2022	BUY	$234.96 - $292.55 $649,664 - $808,900	2,765 New	2,765 $779,000
Q1 2022 May 13, 2022	SELL	$221.42 - $260.97 $322,608 - $380,233	-1,457 Closed	0 $0
Q4 2021 Feb 15, 2022	SELL	$177.01 - $223.45 $615,109 - $776,488	-3,475 Reduced 70.46%	1,457 $320,000
Q3 2021 Nov 15, 2021	BUY	$181.39 - $202.99 $894,615 - $1 Million	4,932 New	4,932 $895,000
Q2 2019 Aug 08, 2019	SELL	$164.61 - $190.37 $1.24 Million - $1.44 Million	-7,540 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$163.73 - $194.7 $1.23 Million - $1.47 Million	7,540 New	7,540 $1.39 Million
Q3 2018 Nov 07, 2018	SELL	$167.73 - $192.74 $1.31 Million - $1.5 Million	-7,789 Closed	0 $0
Q2 2018 Aug 09, 2018	BUY	$145.72 - $169.96 $1.14 Million - $1.32 Million	7,789 New	7,789 $1.32 Million

Others Institutions Holding VRTX

# of Institutions

1,809

Shares Held

239M

Call Options Held

1.95M

Put Options Held

1.14M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $104B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Edgestream Partners, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Edgestream Partners, L.P. with notifications on news.

Account

Edgestream Partners, L.P. Vertex Pharmaceuticals Inc Transaction History